Article citationsMore>>
Weinstock-Guttman, B., Hagemeier, J., Kavak, K.S., Saini, V., Patrick, K., Ramasamy, D.P., Nadeem, M., Carl, E., Hojnacki, D. and Zivadinov R. (2016) Randomised Natalizumab Discontinuation Study: Taper Protocol May Prevent Disease Reactivation. Journal of Neurology, Neurosurgery & Psychiatry, 1-7.
has been cited by the following article:
-
TITLE:
Treatment of Multiple Sclerosis
AUTHORS:
M. Nadeem, O. Mufti, I. Ahsan, R. Naheed, S. M. Faheem
KEYWORDS:
Immune Sequestration, Multiple Sclerosis, Non-Specific Immune Modulation, Lymphocyte-Targeted Therapy
JOURNAL NAME:
Neuroscience and Medicine,
Vol.7 No.2,
June
22,
2016
ABSTRACT: Background: A new method of immune-based therapies has been made and applied on multiple sclerosis patients in last decades. Some of these treatments have a high efficacy and reasonable side effects. In slowing disease progression, present treatments have significant limitations, but often associated with significant adverse effects of immunosuppression, with having a bit low capability to counter the disability. Methods: This is a review meta-analysis of treatment of multiple sclerosis. Results: Thus a valuable aim for multiple sclerosis clinical research is to introduce more effective therapies. Conclusion: It is absolutely necessary to increase the individualized therapy planes development in respect to make better planes to disease-modifying treatments.
Related Articles:
-
Jai Dev Chandel, Nand Lal Singh
-
Nazila Zarghi, Seyed Reza Mazlom, Majid Rahban
-
Mukeba Mbala Eric, Shiwei Xu, Wen Yu, Shengwei Wang, Abdul-Gafar Ahmed, Siek Darith, Mujinga Bukasa Eliane
-
Fossou Jean-Luc Hervé Kouadio, Mamadou Sangare, N’Guessan Nestor Houssou, Marc Ephrem Allialy, Sagbrou Chérubin Djro
-
F. Ly, B. Niang, Y. Keita, C. Dial, A. Sow, A. Sakho Kane, B. S. Ndiaye, A. Sylla, B. Camara, A. Ly Ba, O. Ndiaye